BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30528168)

  • 1. Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
    Long MJC; Lawson AP; Baggio R; Qian Y; Rozhansky L; Fasci D; El Oualid F; Weerapana E; Hedstrom L
    Bioorg Med Chem Lett; 2019 Jan; 29(2):204-211. PubMed ID: 30528168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors.
    Schauer NJ; Magin RS; Liu X; Doherty LM; Buhrlage SJ
    J Med Chem; 2020 Mar; 63(6):2731-2750. PubMed ID: 31682427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and semisynthetic approaches to study and target deubiquitinases.
    Gopinath P; Ohayon S; Nawatha M; Brik A
    Chem Soc Rev; 2016 Jul; 45(15):4171-98. PubMed ID: 27049734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Permeable Activity-Based Ubiquitin Probes Enable Intracellular Profiling of Human Deubiquitinases.
    Gui W; Ott CA; Yang K; Chung JS; Shen S; Zhuang Z
    J Am Chem Soc; 2018 Oct; 140(39):12424-12433. PubMed ID: 30240200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules as tools for functional assessment of deubiquitinating enzyme function.
    Magin RS; Liu X; Felix A; Bratt AS; Chan WC; Buhrlage SJ
    Cell Chem Biol; 2021 Jul; 28(7):1090-1100. PubMed ID: 34089649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of selective deubiquitinase inhibitors.
    Varca AC; Casalena D; Chan WC; Hu B; Magin RS; Roberts RM; Liu X; Zhu H; Seo HS; Dhe-Paganon S; Marto JA; Auld D; Buhrlage SJ
    Cell Chem Biol; 2021 Dec; 28(12):1758-1771.e13. PubMed ID: 34129829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
    Moghadasi SA; Moraes SN; Harris RS
    J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinases: From mechanisms to their inhibition by small molecules.
    Lange SM; Armstrong LA; Kulathu Y
    Mol Cell; 2022 Jan; 82(1):15-29. PubMed ID: 34813758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay Systems for Profiling Deubiquitinating Activity.
    Cho J; Park J; Kim EE; Song EJ
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site.
    Paiva SL; da Silva SR; de Araujo ED; Gunning PT
    J Med Chem; 2018 Jan; 61(2):405-421. PubMed ID: 28076680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1.
    Atkins SL; Motaib S; Wiser LC; Hopcraft SE; Hardy PB; Shackelford J; Foote P; Wade AH; Damania B; Pagano JS; Pearce KH; Whitehurst CB
    Antiviral Res; 2020 Jan; 173():104649. PubMed ID: 31711927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.
    Jin WL; Mao XY; Qiu GZ
    Med Res Rev; 2017 May; 37(3):627-661. PubMed ID: 27775833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes.
    Setz C; Friedrich M; Rauch P; Fraedrich K; Matthaei A; Traxdorf M; Schubert U
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28805676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinases and cancer: A snapshot.
    Singh N; Singh AB
    Crit Rev Oncol Hematol; 2016 Jul; 103():22-6. PubMed ID: 27211605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling the Activity of Deubiquitinating Enzymes Using Chemically Synthesized Ubiquitin-Based Probes.
    Leestemaker Y; de Jong A; Ovaa H
    Methods Mol Biol; 2017; 1491():113-130. PubMed ID: 27778285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of deubiquitylating enzymes in tumorigenesis and development.
    Cheng J; Guo J; North BJ; Wang B; Cui CP; Li H; Tao K; Zhang L; Wei W
    Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188312. PubMed ID: 31449841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating inhibitor discovery for deubiquitinating enzymes.
    Chan WC; Liu X; Magin RS; Girardi NM; Ficarro SB; Hu W; Tarazona Guzman MI; Starnbach CA; Felix A; Adelmant G; Varca AC; Hu B; Bratt AS; DaSilva E; Schauer NJ; Jaen Maisonet I; Dolen EK; Ayala AX; Marto JA; Buhrlage SJ
    Nat Commun; 2023 Feb; 14(1):686. PubMed ID: 36754960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the signalling pathways regulated by deubiquitinases for prostate cancer therapeutics.
    Islam MT; Zhou X; Chen F; Khan MA; Fu J; Chen H
    Cell Biochem Funct; 2019 Jul; 37(5):304-319. PubMed ID: 31062387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Deubiquitinase Substrates in Xenopus Egg Extract.
    Rossio V; Paulo JA; King RW
    Methods Mol Biol; 2023; 2591():219-236. PubMed ID: 36350551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.
    Bushman JW; Donovan KA; Schauer NJ; Liu X; Hu W; Varca AC; Buhrlage SJ; Fischer ES
    Cell Chem Biol; 2021 Jan; 28(1):78-87.e3. PubMed ID: 33007217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.